-
Featured Press Release
During Black History Month Aspira Recognizes the Importance of Bridging the Gap in Ovarian Cancer Risk Assessment Disparities
Learn More -
Investor Event
Aspira to Participate in BTIG’s Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference; Thursday February 18, 2021 9:30am EST
Listen Here
Recent News
Choose a Category:
-
Aspira Women’s Health Inc. Announces it is Now a Highmark Contracted Provider in Pennsylvania and West Virginia
Press Release
For a link to the pdf of this release please click here AUSTIN, Texas — January 28 — Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it expanded access and has become a participating laboratory network provider, for all Pennsylvania and West Virginia commercial health insurance products of Highmark.…
-
Aspira Women’s Health, Inc. to Participate in Virtual Investor Events
Press Release
Aspira to participate in the 10th Annual LifeSci Advisors Corporate Access Event and Biotech Showcase™ from January 6 – 15th, 2021 For a pdf of this press release please click here AUSTIN, Texas — January 4, 2021 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced management will participate in…
-
Aspira Women’s Health, Inc. Announces a Collaborative Agreement with Baylor Genetics for the Co-Development of an Ovarian Cancer Early-Detection test
Press Release
For a pdf of this press release please click here AUSTIN, Texas — November 19, 2020 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced it has entered into a collaborative research agreement with Baylor Genetics (Houston, TX) to co-develop a novel Ovarian Cancer early-detection test. Ovarian cancer accounts for…
-
Aspira Women’s Health Reports Third Quarter 2020 Financial Results
Press Release
Conference Call scheduled for today, November 12th at 4:30 p.m. ET For a pdf of this press release please click here AUSTIN, Texas — November 12, 2020 — Aspira Women’s Health Inc. (“ASPIRA”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the third quarter ended September 30,…
-
Aspira Women’s Health, Inc. Strengthens Executive Leadership with New Appointments
Press Release
Team comprised of distinguished healthcare industry leaders in clinical development, translational medicine, strategy, and operational excellence, joins forces to accelerate innovation and market leadership position For a pdf of this press release please click here AUSTIN, Texas — November 10, 2020 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company today announces…
Upcoming Events
-
March 19 – 25, 2021
Virtual Exhibitor
Society of Gynecologic Oncology (SGO) Annual Meeting
-
April 30 – May 2, 2021
Virtual Exhibitor
American College of Obstetrics and Gynecologists Annual Meeting